Phenotype-genotype profiles in Crohn's disease predicted by genetic markers in autophagy-related genes (GOIA Study II)

Inflammatory Bowel Diseases

Volumn 19, Issue 2, 2013, Pages 230-239

  Durães, Cecília ^a   Machado, José C ^a,b   Portela, Francisco ^c   Rodrigues, Susana ^d   Lago, Paula ^e   Cravo, Marília ^f   Ministro, Paula ^g   Marques, Margarida ^d   Cremers, Isabelle ^h   Freitas, João ⁱ   Cotter, José ^j   Tavares, Lurdes ^k   Matos, Leopoldo ^l   Medeiros, Isabel ^m   Sousa, Rui ⁿ   Ramos, Jaime ^o   Deus, João ^p   Caldeira, Paulo ^q   Chagas, Cristina ^r   Duarte, Maria A ^s   Gonçalves, Raquel ^t   Loureiro, Rui ⁱ   Barros, Luísa ^u   Bastos, Isabel ^v   Cancela, Eugénia ^g   Moraes, Mário C ^w   Moreira, Maria J ^j   Vieira, Ana I ⁱ   Magro, Fernando ^b,c,x   more..

^a UNIVERSITY OF PORTO   (Portugal)

^b University of Porto   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

^d HOSPITAL DE SÃO JOÃO   (Portugal)

^e HOSPITAL DE SANTO ANTÓNIO   (Portugal)

^f INSTITUTO PORTUGUÊS DE ONCOLOGIA DE LISBOA FRANCISCO GENTIL   (Portugal)

^g Hospital Sao Teotonio   (Portugal)

^h São Bernardo Hospital   (Portugal)

ⁱ Hospital of Garcia de Orta   (Portugal)

^j Hospital of Santa Maria ^*  (Portugal)

^k HOSPITAL DE SANTA MARIA   (Portugal)

^l Hospital of ÉVora ^*  (Portugal)

^m Department of Mathematics   (Portugal)

ⁿ Hospital Amato Lusitano   (Portugal)

^o Hospital Capuchos   (Portugal)

^p B Surgery Department   (Portugal)

^q Hospital of Faro   (Portugal)

^r Hospital of Santa Cruz   (Portugal)

^s HOSPITAL DO DIVINO ESPÍRITO SANTO   (Portugal)

^t Department of Psychiatry and Mental Health   (Portugal)

^u Hospital Padre Américo   (Portugal)

^v Hospital Infante D Pedro   (Portugal)

^w Hospital of Portimão   (Portugal)

^x UNIVERSITY OF PORTO   (Portugal)

more..

Author keywords

Association; Autophagy; Crohn's disease; Genotype phenotype; SNP

Indexed keywords

PREDNISOLONE;

ADOLESCENT; ADULT; ARTICLE; AUTOPHAGY; CONTROLLED STUDY; CROHN DISEASE; DISEASE COURSE; FEMALE; FOLLOW UP; GENE FREQUENCY; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HOMOZYGOSITY; HUMAN; INNATE IMMUNITY; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; REMISSION; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING HABIT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; AUTOPHAGY; CARRIER PROTEINS; CASE-CONTROL STUDIES; CHILD; CROHN DISEASE; CYTOKINES; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GPI-LINKED PROTEINS; GTP-BINDING PROTEINS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LECTINS; LOGISTIC MODELS; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PORTUGAL; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84876411425     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.23007     Document Type: Article

References (48)

1. Cho JH, Brant SR. Recent insights into the genetics of inflammatory bowel disease. Gastroenterology. 2011;140:1704-1712.
2. Virgin HW, Todd JA. Metagenomics and personalized medicine. Cell. 2011;147:44-56.
3. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 2001;411:599-603.
4. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 2001;411: 603-606.
5. Economou M, Trikalinos TA, Loizou KT, et al. Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: a meta-analysis. Am J Gastroenterol. 2004;99:2393-2404.
6. Ng SC, Tsoi KK, Kamm MA, et al. Genetics of inflammatory bowel disease in Asia: Systematic review and meta-analysis. Inflamm Bowel Dis. 2012;18:1164-1176.
7. The Wellcome Trust Case Control Consortium. Genome-wide association study of 14, 000 cases of seven common diseases and 3, 000 shared controls. Nature. 2007;447:661-678.
8. Parkes M, Barrett JC, Prescott NJ, et al. Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat Genet. 2007;39:830-832.
9. Hampe J, Franke A, Rosenstiel P, et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn's disease in ATG16L1. Nat Genet. 2007;39:207-211.
10. Barrett JC, Hansoul S, Nicolae DL, et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet. 2008;40:955-962.
11. Márquez A, Conceptión N, Martínez A, et al. Role of ATG16L1 Thr300Ala polymorphism in inflammatory bowel disease: a study in the Spanish population and a meta-analysis. Inflamm Bowel Dis. 2009;15: 1697-1704.
12. Cotterill L, Payne D, Levison S, et al. Replication and meta-analysis of 13, 000 cases defines the risk for interleukin-23 receptor and autophagyrelated 16-like 1 variants in Crohn's disease. Can J Gastroenterol. 2010; 24:297-302.
13. Umeno J, Asano K, Matsushita T, et al. Meta-analysis of published studies identifies eight additional common susceptibility loci for Crohn's disease and ulcerative colitis. Inflamm Bowel Dis. 2011;17:2407-2415.
14. Van Limbergen VJ, Wilson DC, Satsangi J. The genetics of Crohn's disease. Annu Rev Genom Human Genet. 2009;10:89-116.
15. Lesage S, Zouali H, Cézard JP, et al. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet. 2002;70:845-857.
16. Arnott ID, Nimmo ER, Drummond HE, et al. NOD2/CARD15, TLR4 and CD14 mutations in Scottish and Irish Crohn's disease patients: evidence for genetic heterogeneity within Europe? Genes Immun. 2004;5:417-425.
17. Munkholm P. Crohn's disease-occurrence, course and prognosis. An epidemiologic cohort-study. Dan Med Bull. 1997;44:287-302.
18. Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55:749-753.
19. Ramos E, Lopes C, Barros H. Investigating the effect of nonparticipation using a population-based case-control study on myocardial infarction. Ann Epidemiol. 2004;14:437-441.
20. Franchimont D, Vermeire S, El Housni H, et al. Deficient host-bacteria interactions in inflammatory bowel disease? The Toll-like receptor (TLR)- 4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis. Gut. 2004;53:987-992.
21. Zwiers A, Seegers D, Heijmans R, et al. Definition of polymorphisms and haplotypes in the interleukin-12B gene: association with IL-12 production but not with Crohn's disease. Genes Immun. 2004;5:675-677.
22. Rioux JD, Xavier RJ, Taylor KD, et al. Genome-wide association study identifies new susceptibility loci for Crohn's disease and implicates autophagy in disease pathogenesis. Nat Genet. 2007;39:596-604.
23. Seiderer J, Elben I, Diegelmann J, et al. Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD. Inflamm Bowel Dis. 2008;14:437-445.
24. Rigoli L, Romano C, Caruso RA, et al. Clinical significance of NOD2/CARD15 and Toll-like receptor 4 gene single nucleotide polymorphisms in inflammatory bowel disease. World J Gastroenterol. 2008; 14: 4454-4461.
25. Goyette P, Lefebvre C, Ng A, et al. Gene-centric association mapping of chromosome 3p implicates MST1 in IBD pathogenesis. Mucosal Immunol. 2008;1:131-138.
26. Van Limbergen J, Russell RK, Nimmo ER, et al. Germline variants of IRGM in childhood-onset Crohn's disease. Gut. 2009;58:610-611.
27. González RJ, Armengol L, Solé X, et al. SNPassoc: an R package to perform whole genome association studies. Bioinformatics. 2007;23: 644-645.
28. Prescott NJ, Dominy KM, Kubo M, et al. Independent and populationspecific association of risk variants at the IRGM locus with Crohn's disease. Hum Mol Genet. 2010;19:1828-1839.
29. Fabio RR, Concetta RM, Giuseppe C, et al. ATG16L1 contribution to Crohn's disease risk in Sicily. Inflamm Bowel Dis. 2011;17:1635-1636.
30. Meggyesi N, Kiss LS, Koszarska M, et al. NKX2-3 and IRGM variants are associated with disease susceptibility to IBD in Eastern European patients. World J Gastroenterol. 2010;16:5233-5240.
31. Prescott NJ, Fisher SA, Franke A, et al. A nonsynonymous SNP in ATG16L1 predisposes to ileal Crohn's disease and is independent of CARD15 and IBD5. Gastroenterology. 2007;132:1665-1671.
32. Fowler EV, Doecke J, Simms LA, et al. ATG16L1 T300A shows strong associations with disease subgroups in a large Australian IBD population: further support for significant disease heterogeneity. Am J Gastroenterol. 2008;103:2519-2526.
33. Amre DK, Mack DR, Morgan K, et al. Autophagy gene ATG16L1 but not IRGM is associated with Crohn's disease in Canadian children. Inflamm Bowel Dis. 2009;15:501-507.
34. Lakatos PL, Szamosi T, Szilvasi A, et al. ATG16L1 and IL23 receptor (IL23R) genes are associated with disease susceptibility in Hungarian CD patients. Dig Liver Dis. 2008;40:867-873.
35. Weersma RK, Stokkers PC, van Bodegraven AA, et al. Molecular prediction of disease risk and severity in a large Dutch Crohn's disease cohort. Gut. 2009;58:388-395.
36. Wei SC, Ni YH, Yang HI, et al. A hospital-based study of clinical and genetic features of Crohn's disease. J Formos Med Assoc. 2011;110:600-606.
37. Yamazaki K, Onouchi Y, Takazoe M, et al. Association analysis of genetic variants in IL23R, ATG16L1 and 5p13.1 loci with Crohn's disease in Japanese patients. J Hum Genet. 2007;52:575-583.
38. Yang SK, Park M, Lim J, et al. Contribution of IL23R but not ATG16L1 to Crohn's disease susceptibility in Koreans. Inflamm Bowel Dis. 2009;15: 1385-1390.
39. Zhi J, Zhi FC, Chen ZY, et al. Correlation of the autophagosome gene ATG16L1 polymorphism and inflammatory bowel disease. Nan Fang Yi Ke Da Xue Xue Bao. 2008;28:649-651.
40. Walker DG, Bancil AS, Rai PS, et al. Ethnic variation in the frequency of IBD related polymorphisms in IRGM, ATG16L1 and IL23R. Gut. 2011; 60(Suppl 1, BSG abstracts):A223.
41. McCarroll SA, Huett A, Kuballa P, et al. Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn's disease. Nat Genet. 2008;40:1107-1112.
42. Palomino-Morales RJ, Oliver J, Gómez-García M, et al. Association of ATG16L1 and IRGM genes polymorphisms with inflammatory bowel disease: a meta-analysis approach. Genes Immun. 2009;10:356-364.
43. Brest P, Lapaquette P, Souidi M, et al. A synonymous variant in IRGM alters a binding site for miR-196 and causes deregulation of IRGM-dependent xenophagy in Crohn's disease. Nat Genet. 2011;43:242-245.
44. Peter I, Mitchell AA, Ozelius L, et al. Evaluation of 22 genetic variants with Crohn's disease risk in the Ashkenazi Jewish population: a casecontrol study. BMC Med Genet. 2011;6:12:63.
45. Yamazaki K, Takahashi A, Takazoe M, et al. Positive association of genetic variants in the upstream region of NKX2-3 with Crohn's disease in Japanese patients. Gut. 2009;58:228-232.
46. Roberts RL, Hollis-Moffatt JE, Gearry RB, et al. Confirmation of association of IRGM and NCF4 with ileal Crohn's disease in a population-based cohort. Genes Immun. 2008;9:561-565.
47. Tsuji S, Uehori J, Matsumoto M, et al. Human intelectin is a novel soluble lectin that recognizes galactofuranose in carbohydrate chains of bacterial cell wall. J Biol Chem. 2001;276:23456-23463.
48. Wrackmeyer U, Hansen GH, Seya T, et al. Intelectin: a novel lipid raftassociated protein in the enterocyte brush border. Biochemistry. 2006;45: 9188-9197.